Italia markets open in 1 hour 1 minute

EYPT Oct 2024 25.000 put

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
5,00000,0000 (0,00%)
In data: 02:36PM EDT. Mercato aperto.
Schermo intero
Chiusura precedente5,0000
Aperto5,0000
Denaro7,1000
Domanda9,3000
Prezzo d'esercizio25,00
Scadenza2024-10-18
Min-Max giorno5,0000 - 5,0000
Contratto - Min-MaxN/D
Volume17
Open Interest17
  • GlobeNewswire

    EyePoint Pharmaceuticals Strengthens Board and Executive Leadership Team

    – Stuart Duty appointed to EyePoint’s Board of Directors – – George Elston promoted to Executive Vice President – WATERTOWN, Mass., Oct. 16, 2023 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing therapeutics to improve the lives of patients with retinal diseases, today announced the appointment of Stuart Duty to its Board of Directors and the promotion of George Elston to Executive Vice President. “We are excited to welcome

  • GlobeNewswire

    EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

    WATERTOWN, Mass., Sept. 18, 2023 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients with serious eye disorders, today announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Company’s 2023 Long-Term Incentive Plan in accordance with NASDAQ Listing Rule 5635(c)(4). The Company granted stock options to purchase up to an ag

  • GlobeNewswire

    EyePoint Pharmaceuticals Announces Participation at Upcoming Investor Conferences

    WATERTOWN, Mass., Aug. 30, 2023 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious eye disorders, today announced that the Company will participate at the following upcoming conferences: Citi's 18th Annual BioPharma ConferenceForum: 1x1 Investor MeetingsDate: Wednesday, September 6, 2023 H.C. Wainwright 25th Annual Global Investment ConferenceForum: Corp